Flaws in a tumor’s genetic mending kit drive treatment response to immunotherapy – Science Daily
Science Daily |
Flaws in a tumor's genetic mending kit drive treatment response to immunotherapy
Science Daily In an expanded, three-year clinical trial of 86 patients with colorectal and 11 other kinds of cancer that have so-called 'mismatch repair' genetic defects, scientists at Johns Hopkins Medicine and its Bloomberg~Kimmel Institute for Cancer … |
